With reference to earlier letters dated 14th May, 2025, 28th May, 2025 and 04th June, 2025 regarding the Extra-Ordinary General Meeting (EGM) of the Company held today Thursday, 05th June, 2025 and the business mentioned in Notice dated 13th May, 2025 was transacted, Suven Life Sciences has informed that it enclosed the following: Summary of proceedings as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as Annexure - I; The Report of Scrutinizer on remote e-voting and voting at EGM (by electronic means) as Annexure- II.
The above information is a part of company’s filings submitted to BSE.
